Multiple myeloma: some recent developments.
D000368:Aged; D000686:Amyloidosis / Q000276:immunology; D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology; D001809:Blood Viscosity; D002471:Cell Transformation, Neoplastic / Q000187:drug effects / Q000378:metabolism; D002493:Central Nervous System Diseases / Q000150:complications; D002869:Chromosome Aberrations; D025063:Chromosome Disorders; D002999:Clone Cells / Q000276:immunology; D006801:Humans; D007147:Immunoglobulin Light Chains / Q000032:analysis; D007136:Immunoglobulins / Q000096:biosynthesis / Q000235:genetics; D008213:Lymphocyte Activation; D008222:Lymphokines / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000175:diagnosis / Q000209:etiology* / Q000235:genetics; D009367:Neoplasm Staging; D011379:Prognosis; D013601:T-Lymphocytes / Q000145:classification
D007147:Immunoglobulin Light Chains; D007136:Immunoglobulins; D008222:Lymphokines; C008718:osteoclast activating factor